These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 22990329)
21. Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study. Cordero A; Rodriguez Padial L; Batalla A; López Barreiro L; Torres Calvo F; Castellano JM; Ruiz E; Bertomeu-Martínez V; Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27957818 [TBL] [Abstract][Full Text] [Related]
22. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey. Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D; Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002 [TBL] [Abstract][Full Text] [Related]
23. Exploration of the methodological quality and clinical usefulness of a cross-sectional sample of published guidance about exercise training and physical activity for the secondary prevention of coronary heart disease. Abell B; Glasziou P; Hoffmann T BMC Cardiovasc Disord; 2017 Jun; 17(1):153. PubMed ID: 28610621 [TBL] [Abstract][Full Text] [Related]
24. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization. Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848 [TBL] [Abstract][Full Text] [Related]
25. Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States. Sukul D; Bhatt DL; Seth M; Zakroysky P; Wojdyla D; Rumsfeld JS; Wang T; Rao SV; Gurm HS JACC Cardiovasc Interv; 2018 Feb; 11(4):342-350. PubMed ID: 29471947 [TBL] [Abstract][Full Text] [Related]
26. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers. Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901 [TBL] [Abstract][Full Text] [Related]
27. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896 [TBL] [Abstract][Full Text] [Related]
28. The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services. Tu JV; Chu A; Donovan LR; Ko DT; Booth GL; Tu K; Maclagan LC; Guo H; Austin PC; Hogg W; Kapral MK; Wijeysundera HC; Atzema CL; Gershon AS; Alter DA; Lee DS; Jackevicius CA; Bhatia RS; Udell JA; Rezai MR; Stukel TA Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):204-12. PubMed ID: 25648464 [TBL] [Abstract][Full Text] [Related]
29. Appropriate Use Criteria and Health Status Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN-CTO Registry. Saxon JT; Grantham JA; Salisbury AC; Sapontis J; Lombardi WL; Karmpaliotis D; Moses J; Nicholson WJ; Tang Y; Cohen DJ; Spertus JA; Safley DM Circ Cardiovasc Interv; 2020 Feb; 13(2):e008448. PubMed ID: 32069112 [TBL] [Abstract][Full Text] [Related]
30. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Peiris D; Usherwood T; Panaretto K; Harris M; Hunt J; Redfern J; Zwar N; Colagiuri S; Hayman N; Lo S; Patel B; Lyford M; MacMahon S; Neal B; Sullivan D; Cass A; Jackson R; Patel A Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):87-95. PubMed ID: 25587090 [TBL] [Abstract][Full Text] [Related]
31. Guideline-Appropriate Care and In-Hospital Outcomes in Patients With Heart Failure in Teaching and Nonteaching Hospitals: Findings From Get With The Guidelines-Heart Failure. Patel DB; Shah RM; Bhatt DL; Liang L; Schulte PJ; DeVore AD; Hernandez AF; Heidenreich PA; Yancy CW; Fonarow GC Circ Cardiovasc Qual Outcomes; 2016 Nov; 9(6):757-766. PubMed ID: 27780849 [TBL] [Abstract][Full Text] [Related]
32. ASPIRE-3-PREVENT: a cross-sectional survey of preventive care after a coronary event across the UK. Jennings CS; Kotseva K; Bassett P; Adamska A; Wood D; Open Heart; 2020 Apr; 7(1):. PubMed ID: 32354740 [TBL] [Abstract][Full Text] [Related]
33. Design and validation of a medication assessment tool for cancer pain management. Håkonsen GD; Hudson S; Loennechen T Pharm World Sci; 2006 Dec; 28(6):342-51. PubMed ID: 17120130 [TBL] [Abstract][Full Text] [Related]
34. A medication assessment tool to evaluate adherence to medication guideline in asthmatic children. Liu HP; Chen HY; Johnson J; Lin YM Int J Clin Pharm; 2013 Apr; 35(2):289-95. PubMed ID: 23359031 [TBL] [Abstract][Full Text] [Related]
35. The 2018 Chitranjan S. Ranawat, MD Award: Developing and Implementing a Novel Institutional Guideline Strategy Reduced Postoperative Opioid Prescribing After TKA and THA. Wyles CC; Hevesi M; Trousdale ER; Ubl DS; Gazelka HM; Habermann EB; Trousdale RT; Pagnano MW; Mabry TM Clin Orthop Relat Res; 2019 Jan; 477(1):104-113. PubMed ID: 30794233 [TBL] [Abstract][Full Text] [Related]
36. Impact of Sustained Use of a Multifaceted Computerized Quality Improvement Intervention for Cardiovascular Disease Management in Australian Primary Health Care. Patel B; Peiris D; Usherwood T; Li Q; Harris M; Panaretto K; Zwar N; Patel A J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066447 [TBL] [Abstract][Full Text] [Related]
37. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U; Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307 [TBL] [Abstract][Full Text] [Related]
38. Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation). Barnett AS; Kim S; Fonarow GC; Thomas LE; Reiffel JA; Allen LA; Freeman JV; Naccarelli G; Mahaffey KW; Go AS; Kowey PR; Ansell JE; Gersh BJ; Hylek EM; Peterson ED; Piccini JP Circ Arrhythm Electrophysiol; 2017 Nov; 10(11):. PubMed ID: 29141842 [TBL] [Abstract][Full Text] [Related]
39. Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospective review. Abell JE; Laing SM; Barker TC; Norry EC; Starzyk K; Goodman SG; Dellborg M; Steg PG; Giugliano RP Eur Heart J Cardiovasc Pharmacother; 2017 Oct; 3(4):214-220. PubMed ID: 28430984 [TBL] [Abstract][Full Text] [Related]
40. Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry. Boivin-Proulx LA; Deneault-Marchand A; Matteau A; Mansour S; Gobeil F; Camm JA; Fox KAA; Potter BJ Clin Cardiol; 2020 Mar; 43(3):216-221. PubMed ID: 31850592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]